Niall O'Donnell

Niall O'Donnell has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Mirum Pharmaceuticals, Inc., OnKure Therapeutics, Inc. and Spruce Biosciences, Inc. Between 11 November 2022 and 8 May 2023, the trades on record add up to 3 filings.

In open-market terms, that means 2 purchases worth €2.8M on one side and 1 sale worth €3.4M on the other. The net balance comes to €637k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2023 alone, the filings show 2 purchases and no sales.

The record was last updated on 16 May 2023 with an open-market purchase (€1.9M) in Spruce Biosciences, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.